Norbert Krug

7.7k total citations
87 papers, 3.5k citations indexed

About

Norbert Krug is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Norbert Krug has authored 87 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 37 papers in Pulmonary and Respiratory Medicine and 25 papers in Immunology and Allergy. Recurrent topics in Norbert Krug's work include Asthma and respiratory diseases (44 papers), Allergic Rhinitis and Sensitization (24 papers) and Neonatal Respiratory Health Research (19 papers). Norbert Krug is often cited by papers focused on Asthma and respiratory diseases (44 papers), Allergic Rhinitis and Sensitization (24 papers) and Neonatal Respiratory Health Research (19 papers). Norbert Krug collaborates with scholars based in Germany, United States and Switzerland. Norbert Krug's co-authors include Jens M. Hohlfeld, Armin Braun, Veit J. Erpenbeck, Thomas Tschernig, Frank Schaumann, Veit J. Erpenbeck, Heinz G. Hoymann, H Fabel, Jörg Köhl and Birgit Luettig and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Norbert Krug

84 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Krug Germany 37 1.4k 1.2k 978 589 364 87 3.5k
Angela Haczku United States 40 2.1k 1.5× 1.4k 1.2× 1.7k 1.7× 595 1.0× 334 0.9× 105 4.3k
Seung‐Hyun Kim South Korea 39 2.2k 1.6× 1.1k 0.9× 1.2k 1.2× 550 0.9× 243 0.7× 246 5.2k
Tania Maes Belgium 37 1.7k 1.2× 1.4k 1.1× 1.4k 1.5× 462 0.8× 479 1.3× 87 4.0k
Alessandro Vatrella Italy 41 2.4k 1.7× 1.9k 1.6× 822 0.8× 800 1.4× 317 0.9× 170 4.6k
Joachim Kuehr Germany 38 2.1k 1.6× 1.2k 1.0× 623 0.6× 1.5k 2.5× 407 1.1× 84 3.8k
Kurt G. Tournoy Belgium 36 1.1k 0.8× 1.9k 1.6× 737 0.8× 342 0.6× 248 0.7× 87 3.4k
Marek L. Kowalski Poland 35 2.0k 1.5× 923 0.8× 549 0.6× 1.3k 2.2× 140 0.4× 187 4.3k
David H. Eidelman Canada 43 2.3k 1.7× 2.2k 1.8× 1.1k 1.1× 414 0.7× 277 0.8× 157 5.1k
David Proud United States 31 1.8k 1.3× 738 0.6× 632 0.6× 1.3k 2.2× 124 0.3× 88 3.3k
Machteld N. Hylkema Netherlands 37 1.5k 1.1× 1.4k 1.1× 1.1k 1.2× 291 0.5× 407 1.1× 109 3.9k

Countries citing papers authored by Norbert Krug

Since Specialization
Citations

This map shows the geographic impact of Norbert Krug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Krug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Krug more than expected).

Fields of papers citing papers by Norbert Krug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Krug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Krug. The network helps show where Norbert Krug may publish in the future.

Co-authorship network of co-authors of Norbert Krug

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Krug. A scholar is included among the top collaborators of Norbert Krug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Krug. Norbert Krug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogel‐Claussen, Jens, Julius Renne, Jan B. Hinrichs, et al.. (2014). Quantification of Pulmonary Inflammation after Segmental Allergen Challenge Using Turbo-Inversion Recovery-Magnitude Magnetic Resonance Imaging. American Journal of Respiratory and Critical Care Medicine. 189(6). 650–657. 26 indexed citations
2.
Hohlfeld, Jens M., Norbert Krug, Agnieszka Turowska, et al.. (2013). Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma. European Respiratory Journal. 42(Suppl 57). 4856–4856. 1 indexed citations
3.
Tank, Jens, Heike Biller, Karsten Heusser, et al.. (2011). Effect of Acute Ozone Induced Airway Inflammation on Human Sympathetic Nerve Traffic: A Randomized, Placebo Controlled, Crossover Study. PLoS ONE. 6(4). e18737–e18737. 15 indexed citations
4.
Atochina‐Vasserman, Elena N., Carla Winkler, Frank Schaumann, et al.. (2010). Segmental Allergen Challenge Alters Multimeric Structure and Function of Surfactant Protein D in Humans. American Journal of Respiratory and Critical Care Medicine. 183(7). 856–864. 36 indexed citations
5.
Weigt, Henning, Christina Nassenstein, Thomas Tschernig, et al.. (2005). Efficacy of Macrophage-activating Lipopeptide-2 Combined with Interferon-γ in a Murine Asthma Model. American Journal of Respiratory and Critical Care Medicine. 172(5). 566–572. 25 indexed citations
6.
Fuchs, Barbara, Wilfried Bautsch, Jörg Köhl, et al.. (2005). Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation. The Journal of Immunology. 174(2). 783–789. 90 indexed citations
7.
Schaumann, Frank, Paul J. A. Borm, Mike Pitz, et al.. (2004). Metal-rich Ambient Particles (Particulate Matter2.5) Cause Airway Inflammation in Healthy Subjects. American Journal of Respiratory and Critical Care Medicine. 170(8). 898–903. 234 indexed citations
8.
Weigt, Henning, Peter F. Mühlradt, Michael Larbig, Norbert Krug, & Armin Braun. (2004). The Toll-Like Receptor-2/6 Agonist Macrophage-Activating Lipopeptide-2 Cooperates with IFN-γ to Reverse the Th2 Skew in an In Vitro Allergy Model. The Journal of Immunology. 172(10). 6080–6086. 30 indexed citations
9.
Erpenbeck, Veit J., Jörn Elsner, Harald Krentel, et al.. (2003). Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 169(5). 578–586. 47 indexed citations
10.
Fehrenbach, Antonia, Jens M. Hohlfeld, Paul A. Stevens, et al.. (2003). Surfactant Homeostasis Is Maintained In Vivo during Keratinocyte Growth Factor–induced Rat Lung Type II Cell Hyperplasia. American Journal of Respiratory and Critical Care Medicine. 167(9). 1264–1270. 18 indexed citations
11.
Erpenbeck, Veit J., et al.. (2003). Increased Expression of Interleukin-9 Messenger RNA After Segmental Allergen Challenge in Allergic Asthmatics. CHEST Journal. 123(3). 370S–370S. 29 indexed citations
12.
Erpenbeck, Veit J., et al.. (2003). Increased Messenger RNA Expression of c-maf and GATA-3 After Segmental Allergen Challenge in Allergic Asthmatics. CHEST Journal. 123(3). 370S–371S. 16 indexed citations
13.
Krug, Norbert, Thomas Tschernig, Veit J. Erpenbeck, Jens M. Hohlfeld, & Jörg Köhl. (2001). Complement Factors C3a and C5a are Increased in Bronchoalveolar Lavage Fluid after Segmental Allergen Provocation in Subjects with Asthma. American Journal of Respiratory and Critical Care Medicine. 164(10). 1841–1843. 150 indexed citations
14.
Schuster, Martín, Thomas Tschernig, Norbert Krug, & Reinhard Pabst. (2000). Lymphocytes Migrate from the Blood into the Bronchoalveolar Lavage and Lung Parenchyma in the Asthma Model of the Brown Norway Rat. American Journal of Respiratory and Critical Care Medicine. 161(2). 558–566. 67 indexed citations
15.
Krug, Norbert, William W. Cruikshank, Thomas Tschernig, et al.. (2000). Interleukin 16 and T-cell Chemoattractant Activity in Bronchoalveolar Lavage 24 Hours after Allergen Challenge in Asthma. American Journal of Respiratory and Critical Care Medicine. 162(1). 105–111. 31 indexed citations
16.
Hohlfeld, Jens M., Göran Enhörning, Veit J. Erpenbeck, et al.. (1999). Dysfunction of Pulmonary Surfactant in Asthmatics after Segmental Allergen Challenge. American Journal of Respiratory and Critical Care Medicine. 159(6). 1803–1809. 96 indexed citations
17.
Krug, Norbert, Thomas Jung, Kathrin Wagner, et al.. (1998). Frequencies of T Cells Expressing Interleukin-4 and Interleukin-5 in Atopic Asthmatic Children: Comparison with Atopic Asthmatic Adults. American Journal of Respiratory and Critical Care Medicine. 158(3). 754–759. 31 indexed citations
18.
Hohlfeld, Jens M., Ezgi Tiryaki, H Hamm, et al.. (1998). Pulmonary Surfactant Activity Is Impaired in Lung Transplant Recipients. American Journal of Respiratory and Critical Care Medicine. 158(3). 706–712. 54 indexed citations
19.
Schulz, Ulrich, et al.. (1996). Identification of eosinophils by flow cytometry. Cytometry. 23(2). 150–158. 39 indexed citations
20.
Schulz, Ulrich, et al.. (1996). Identification of eosinophils by flow cytometry. Cytometry. 23(2). 150–158. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026